Description
The emergence of ketamine–previously known as a combat anesthetic and club drug–as a treatment for depression.Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years–in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug–that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
Additional information
| Weight | 0.1589 kg |
|---|---|
| Dimensions | 1.3716 × 12.7 × 17.78 cm |
| Author(s) | |
| Format Old` | |
| Language | |
| Pages | 208 |
| Publisher | |
| Year Published | 2021-2-16 |
| Imprint | |
| Publication City/Country | USA |
| ISBN 10 | 0262542242 |
| About The Author | Bita Moghaddam is a leading researcher in the field of neuropsychopharmacology. She is Ruth Matarazzo Professor of Behavioral Neuroscience at Oregon Health and Science University in Portland. |
| Table Of Content | Series Foreword ix Preface xi 1 The Molecule Ketamine 1 2 Uses of Ketamine 17 3 Neuroscience of Ketamine 31 4 Ketamine as an Antidepressant 65 5 How Does Ketamine Produce Antidepressant Effects? 101 6 Safety Concerns with Ketamine and Esketamine 121 7 Where Do We Go from Here? 141 Acknowledgments 155 Glossary 157 Notes 161 Further Reading 177 Index 179 |
Only logged in customers who have purchased this product may leave a review.





Reviews
There are no reviews yet.